drugset / Trial / NCT02821819
Random-start Ovarian Stimulation in Egg-donors (ROSE)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this prospective single-center study is to evaluate the laboratory outcome after random start ovarian stimulation in oocyte donors. The study will be performed in egg-donors but this type of treatment has the potential to be implemented in general infertility population.
Timeline
- Start
- 2017-01-10
- Primary completion
- 2018-01-12
- Completion
- 2018-01-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bravelle | Unknown | 150 iu | — |
| Subject | Bravelle | Unknown | 225 iu | — |
| Background | Cetrorelix | Other / unclassified | 0.25 mg | — |
| Background | Triptorelin | Other / unclassified | 0.2 mg | — |